Knight Therapeutics Inc. (TSX:GUD)

Knight Therapeutics Revenue

Knight Therapeutics had revenue of 107.36M CAD in the quarter ending June 30, 2025, with 12.33% growth. This brings the company's revenue in the last twelve months to 384.56M, up 13.82% year-over-year. In the year 2024, Knight Therapeutics had annual revenue of 371.30M with 13.13% growth.

• Revenue (ttm): 384.56M
• Revenue Growth: +13.82%
• P/S Ratio: 1.51
• Revenue / Employee: 516.19K
• Employees: 745
• Market Cap: 581.12M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	371.30M	43.11M	13.13%
Dec 31, 2023	328.20M	34.64M	11.80%
Dec 31, 2022	293.56M	50.09M	20.57%
Dec 31, 2021	243.48M	43.96M	22.03%
Dec 31, 2020	199.52M	152.06M	320.39%